Information about Pharma Invest Management
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Pharma Invest Management (SRL)

BE 0808.104.525

Rue Louis Pasteur 3, 4630 Soumagne
Company information
Status
Active
Enterprise number
BE0808.104.525
VAT liability
Yes
Established
28-11-2008
Last balance sheet year
2023
Company size
Small 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharma Invest Management
{{translate("download")}}

Publications in the Belgian Official Journal from Pharma Invest Management

Date Publication
24-01-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Miscellaneous - Resignations, Appointments (FR)
09-12-2008 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Pharma Invest Management?
The VAT number of Pharma Invest Management is BE0808104525.
When was Pharma Invest Management founded?
Pharma Invest Management was founded on 28-11-2008.
What is the address of Pharma Invest Management?
The current registered office of Pharma Invest Management is located at Rue Louis Pasteur 3, 4630 Soumagne.
When was the last time Pharma Invest Management filed their annual financial statements?
The most recent financial statements of Pharma Invest Management were filed on 17-07-2024. You can view them here.
How many employees does Pharma Invest Management have?
There are currently no employees working at Pharma Invest Management or no workforce information is available.
What is the annual turnover of Pharma Invest Management?
At the time of its most recent financial statements, Pharma Invest Management did not publish any turnover figures. Pharma Invest Management reported a gross margin of €93,395.99.

Sources